1	Researchers	_	_	NNS	_	_	_	_	_
2	identify	_	_	VBP	_	_	_	_	_
3	protein	_	_	NN	_	_	_	_	_
4	responsible	_	_	JJ	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	malaria	_	_	NN	_	_	_	_	_
7	transmission	_	_	NN	_	_	_	_	_


1	Tuesday	_	_	NNP	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	February	_	_	NNP	_	_	_	_	_
4	25	_	_	CD	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	2014	_	_	CD	_	_	_	_	_


1	Plasmodium	_	_	NN	_	_	_	_	_
2	falciparum	_	_	NN	_	_	_	_	_


1	gametocytes	_	_	NNS	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Two	_	_	CD	_	_	_	_	_
2	groups	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	researchers	_	_	NNS	_	_	_	_	_
5	have	_	_	VBP	_	_	_	_	_
6	independently	_	_	RB	_	_	_	_	_
7	identified	_	_	VBN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	protein	_	_	NN	_	_	_	_	_
11	responsible	_	_	JJ	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	malaria	_	_	NN	_	_	_	_	_
14	transmission	_	_	NN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	mosquitoes	_	_	NNS	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	studies	_	_	NNS	_	_	_	_	_
19	published	_	_	VBN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	journal	_	_	NN	_	_	_	_	_
22	Nature	_	_	NNP	_	_	_	_	_
23	on	_	_	IN	_	_	_	_	_
24	Sunday	_	_	NNP	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	scientists	_	_	NNS	_	_	_	_	_
3	found	_	_	VBD	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	direct	_	_	JJ	_	_	_	_	_
6	relationship	_	_	NN	_	_	_	_	_
7	between	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	protein	_	_	NN	_	_	_	_	_
10	AP2-G	_	_	NNP	_	_	_	_	_
11	's	_	_	POS	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	malaria	_	_	NN	_	_	_	_	_
14	gametocytes	_	_	NNS	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	male	_	_	JJ	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	female	_	_	JJ	_	_	_	_	_
19	sexual	_	_	JJ	_	_	_	_	_
20	forms	_	_	NNS	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	production	_	_	NN	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	which	_	_	WDT	_	_	_	_	_
25	is	_	_	VBZ	_	_	_	_	_
26	necessary	_	_	JJ	_	_	_	_	_
27	for	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	transmission	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Only	_	_	RB	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	sexual	_	_	JJ	_	_	_	_	_
4	forms	_	_	NNS	_	_	_	_	_
5	infect	_	_	VBP	_	_	_	_	_
6	mosquitoes	_	_	NNS	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	sexual	_	_	JJ	_	_	_	_	_
9	reproduction	_	_	NN	_	_	_	_	_
10	occurs	_	_	VBZ	_	_	_	_	_
11	within	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	mosquito	_	_	NN	_	_	_	_	_
14	digestive	_	_	JJ	_	_	_	_	_
15	tract	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Malaria	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	caused	_	_	VBN	_	_	_	_	_
4	by	_	_	IN	_	_	_	_	_
5	Plasmodium	_	_	NN	_	_	_	_	_
6	parasites	_	_	NNS	_	_	_	_	_
7	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	initially	_	_	RB	_	_	_	_	_
3	separate	_	_	JJ	_	_	_	_	_
4	teams	_	_	NNS	_	_	_	_	_
5	looked	_	_	VBD	_	_	_	_	_
6	at	_	_	IN	_	_	_	_	_
7	different	_	_	JJ	_	_	_	_	_
8	plasmodium	_	_	NN	_	_	_	_	_
9	species	_	_	NNS	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	One	_	_	CD	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	an	_	_	DT	_	_	_	_	_
4	international	_	_	JJ	_	_	_	_	_
5	group	_	_	NN	_	_	_	_	_
6	led	_	_	VBN	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	Manuel	_	_	NNP	_	_	_	_	_
9	Llinás	_	_	NNP	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	Penn	_	_	NNP	_	_	_	_	_
12	State	_	_	NNP	_	_	_	_	_
13	University	_	_	NNP	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	US	_	_	NNP	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	examined	_	_	VBD	_	_	_	_	_
19	Plasmodium	_	_	NNP	_	_	_	_	_
20	falciparum	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	which	_	_	WDT	_	_	_	_	_
23	is	_	_	VBZ	_	_	_	_	_
24	responsible	_	_	JJ	_	_	_	_	_
25	for	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	worst	_	_	JJS	_	_	_	_	_
28	form	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	human	_	_	JJ	_	_	_	_	_
31	malarial	_	_	JJ	_	_	_	_	_
32	infections	_	_	NNS	_	_	_	_	_
33	;	_	_	:	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	other	_	_	JJ	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	led	_	_	VBN	_	_	_	_	_
38	by	_	_	IN	_	_	_	_	_
39	UK	_	_	NNP	_	_	_	_	_
40	scientists	_	_	NNS	_	_	_	_	_
41	Oliver	_	_	NNP	_	_	_	_	_
42	Billker	_	_	NNP	_	_	_	_	_
43	from	_	_	IN	_	_	_	_	_
44	the	_	_	DT	_	_	_	_	_
45	Wellcome	_	_	NNP	_	_	_	_	_
46	Trust	_	_	NNP	_	_	_	_	_
47	Sanger	_	_	NNP	_	_	_	_	_
48	Institute	_	_	NNP	_	_	_	_	_
49	in	_	_	IN	_	_	_	_	_
50	England	_	_	NNP	_	_	_	_	_
51	and	_	_	CC	_	_	_	_	_
52	Andy	_	_	NNP	_	_	_	_	_
53	Waters	_	_	NNP	_	_	_	_	_
54	from	_	_	IN	_	_	_	_	_
55	University	_	_	NNP	_	_	_	_	_
56	of	_	_	IN	_	_	_	_	_
57	Glasgow	_	_	NNP	_	_	_	_	_
58	in	_	_	IN	_	_	_	_	_
59	Scotland	_	_	NNP	_	_	_	_	_
60	,	_	_	,	_	_	_	_	_
61	looked	_	_	VBD	_	_	_	_	_
62	at	_	_	IN	_	_	_	_	_
63	Plasmodium	_	_	NNP	_	_	_	_	_
64	berghei	_	_	NNP	_	_	_	_	_
65	,	_	_	,	_	_	_	_	_
66	which	_	_	WDT	_	_	_	_	_
67	infects	_	_	VBZ	_	_	_	_	_
68	rodents	_	_	NNS	_	_	_	_	_
69	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	P.	_	_	NN	_	_	_	_	_
3	falciparum	_	_	NN	_	_	_	_	_
4	group	_	_	NN	_	_	_	_	_
5	was	_	_	VBD	_	_	_	_	_
6	kickstarted	_	_	VBN	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	research	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	Spain	_	_	NNP	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	found	_	_	VBD	_	_	_	_	_
13	different	_	_	JJ	_	_	_	_	_
14	organisms	_	_	NNS	_	_	_	_	_
15	from	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	same	_	_	JJ	_	_	_	_	_
18	strain	_	_	NN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	identical	_	_	JJ	_	_	_	_	_
21	DNA	_	_	NNP	_	_	_	_	_
22	had	_	_	VBD	_	_	_	_	_
23	varying	_	_	VBG	_	_	_	_	_
24	levels	_	_	NNS	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	AP2-G	_	_	NNP	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	with	_	_	IN	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	strong	_	_	JJ	_	_	_	_	_
31	correlation	_	_	NN	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	their	_	_	PRP$	_	_	_	_	_
34	levels	_	_	NNS	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	sexual	_	_	JJ	_	_	_	_	_
37	activity	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	more	_	_	RBR	_	_	_	_	_
3	AP2-G	_	_	NNP	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	higher	_	_	JJR	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	rate	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	gametocyte	_	_	NN	_	_	_	_	_
11	formation	_	_	NN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	Researchers	_	_	NNS	_	_	_	_	_
2	in	_	_	IN	_	_	_	_	_
3	England	_	_	NNP	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	later	_	_	RBR	_	_	_	_	_
6	also	_	_	RB	_	_	_	_	_
7	drawn	_	_	VBN	_	_	_	_	_
8	into	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	international	_	_	JJ	_	_	_	_	_
11	team	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	analyzed	_	_	VBD	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	genomes	_	_	NNS	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	two	_	_	CD	_	_	_	_	_
18	mutated	_	_	VBN	_	_	_	_	_
19	strains	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	P.	_	_	NN	_	_	_	_	_
22	falciparum	_	_	NN	_	_	_	_	_
23	which	_	_	WDT	_	_	_	_	_
24	were	_	_	VBD	_	_	_	_	_
25	both	_	_	DT	_	_	_	_	_
26	unable	_	_	JJ	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	form	_	_	VB	_	_	_	_	_
29	gametocytes	_	_	NNS	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	found	_	_	VBD	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	gene	_	_	NN	_	_	_	_	_
6	responsible	_	_	JJ	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	producing	_	_	VBG	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	AP2-G	_	_	NNP	_	_	_	_	_
11	protein	_	_	NN	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	only	_	_	JJ	_	_	_	_	_
15	common	_	_	JJ	_	_	_	_	_
16	non-functioning	_	_	JJ	_	_	_	_	_
17	gene	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	international	_	_	JJ	_	_	_	_	_
3	team	_	_	NN	_	_	_	_	_
4	found	_	_	VBD	_	_	_	_	_
5	found	_	_	VBN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	AP2-G	_	_	NNP	_	_	_	_	_
8	protein	_	_	NN	_	_	_	_	_
9	catalyzes	_	_	VBZ	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	transmission	_	_	NN	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	activating	_	_	VBG	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	relevant	_	_	JJ	_	_	_	_	_
16	gene	_	_	NN	_	_	_	_	_
17	set	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	parasite	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Women	_	_	NNS	_	_	_	_	_
2	tend	_	_	VBP	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	their	_	_	PRP$	_	_	_	_	_
5	malaria-infected	_	_	JJ	_	_	_	_	_
6	babies	_	_	NNS	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	Angola	_	_	NNP	_	_	_	_	_
9	.	_	_	.	_	_	_	_	_


1	Image	_	_	NN	_	_	_	_	_
2	:	_	_	:	_	_	_	_	_
3	USAID	_	_	NNP	_	_	_	_	_
4	Africa	_	_	NNP	_	_	_	_	_
5	.	_	_	.	_	_	_	_	_


1	Both	_	_	DT	_	_	_	_	_
2	teams	_	_	NNS	_	_	_	_	_
3	confirmed	_	_	VBD	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	finding	_	_	NN	_	_	_	_	_
6	by	_	_	IN	_	_	_	_	_
7	gene	_	_	NN	_	_	_	_	_
8	therapy	_	_	NN	_	_	_	_	_
9	—	_	_	:	_	_	_	_	_
10	both	_	_	DT	_	_	_	_	_
11	by	_	_	IN	_	_	_	_	_
12	adding	_	_	VBG	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	gene	_	_	NN	_	_	_	_	_
15	into	_	_	IN	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	mutated	_	_	VBN	_	_	_	_	_
18	strain	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	observing	_	_	VBG	_	_	_	_	_
21	its	_	_	PRP$	_	_	_	_	_
22	ability	_	_	NN	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	form	_	_	VB	_	_	_	_	_
25	gametocytes	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	other	_	_	JJ	_	_	_	_	_
30	way	_	_	NN	_	_	_	_	_
31	round	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	parasites	_	_	NNS	_	_	_	_	_
3	exist	_	_	VBP	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	mosquito	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	then	_	_	RB	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	human	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	require	_	_	VBP	_	_	_	_	_
15	subsequent	_	_	JJ	_	_	_	_	_
16	transmission	_	_	NN	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	parasite	_	_	NN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	spread	_	_	VB	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	transmission	_	_	NN	_	_	_	_	_
3	can	_	_	MD	_	_	_	_	_
4	only	_	_	RB	_	_	_	_	_
5	happen	_	_	VB	_	_	_	_	_
6	through	_	_	IN	_	_	_	_	_
7	gametocytes	_	_	NNS	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	parasite	_	_	NN	_	_	_	_	_
3	triggers	_	_	VBZ	_	_	_	_	_
4	formation	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	sexual	_	_	JJ	_	_	_	_	_
8	gametocytes	_	_	NNS	_	_	_	_	_
9	into	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	human	_	_	NN	_	_	_	_	_
12	's	_	_	POS	_	_	_	_	_
13	circulatory	_	_	JJ	_	_	_	_	_
14	system	_	_	NN	_	_	_	_	_
15	every	_	_	DT	_	_	_	_	_
16	two	_	_	CD	_	_	_	_	_
17	days	_	_	NNS	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	small	_	_	JJ	_	_	_	_	_
20	quantities	_	_	NNS	_	_	_	_	_
21	—	_	_	:	_	_	_	_	_
22	not	_	_	RB	_	_	_	_	_
23	wasting	_	_	VBG	_	_	_	_	_
24	energy	_	_	NN	_	_	_	_	_
25	on	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	process	_	_	NN	_	_	_	_	_
28	at	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	dry	_	_	JJ	_	_	_	_	_
31	time	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	year	_	_	NN	_	_	_	_	_
34	when	_	_	WRB	_	_	_	_	_
35	few	_	_	JJ	_	_	_	_	_
36	mosquitoes	_	_	NNS	_	_	_	_	_
37	are	_	_	VBP	_	_	_	_	_
38	available	_	_	JJ	_	_	_	_	_
39	—	_	_	:	_	_	_	_	_
40	but	_	_	CC	_	_	_	_	_
41	little	_	_	JJ	_	_	_	_	_
42	was	_	_	VBD	_	_	_	_	_
43	known	_	_	VBN	_	_	_	_	_
44	about	_	_	IN	_	_	_	_	_
45	the	_	_	DT	_	_	_	_	_
46	mechanism	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Dr.	_	_	NNP	_	_	_	_	_
2	Oliver	_	_	NNP	_	_	_	_	_
3	Billker	_	_	NNP	_	_	_	_	_
4	commented	_	_	VBD	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	potential	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	getting	_	_	VBG	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	transmission	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	malaria	_	_	NN	_	_	_	_	_
14	under	_	_	IN	_	_	_	_	_
15	control	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	unlike	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	existing	_	_	VBG	_	_	_	_	_
20	focus	_	_	NN	_	_	_	_	_
21	on	_	_	IN	_	_	_	_	_
22	addressing	_	_	VBG	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	phrase	_	_	NN	_	_	_	_	_
25	causing	_	_	VBG	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	clinical	_	_	JJ	_	_	_	_	_
28	symptoms	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	"	_	_	``	_	_	_	_	_
31	Current	_	_	JJ	_	_	_	_	_
32	drugs	_	_	NNS	_	_	_	_	_
33	treat	_	_	VBP	_	_	_	_	_
34	patients	_	_	NNS	_	_	_	_	_
35	by	_	_	IN	_	_	_	_	_
36	killing	_	_	VBG	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	sexless	_	_	JJ	_	_	_	_	_
39	form	_	_	NN	_	_	_	_	_
40	of	_	_	IN	_	_	_	_	_
41	the	_	_	DT	_	_	_	_	_
42	parasite	_	_	NN	_	_	_	_	_
43	in	_	_	IN	_	_	_	_	_
44	their	_	_	PRP$	_	_	_	_	_
45	blood	_	_	NN	_	_	_	_	_
46	—	_	_	:	_	_	_	_	_
47	this	_	_	DT	_	_	_	_	_
48	is	_	_	VBZ	_	_	_	_	_
49	the	_	_	DT	_	_	_	_	_
50	detrimental	_	_	JJ	_	_	_	_	_
51	stage	_	_	NN	_	_	_	_	_
52	of	_	_	IN	_	_	_	_	_
53	the	_	_	DT	_	_	_	_	_
54	malaria	_	_	NN	_	_	_	_	_
55	lifecycle	_	_	NN	_	_	_	_	_
56	that	_	_	WDT	_	_	_	_	_
57	causes	_	_	VBZ	_	_	_	_	_
58	illness	_	_	NN	_	_	_	_	_
59	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	now	_	_	RB	_	_	_	_	_
6	widely	_	_	RB	_	_	_	_	_
7	accepted	_	_	VBN	_	_	_	_	_
8	that	_	_	IN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	eliminate	_	_	VB	_	_	_	_	_
11	malaria	_	_	NN	_	_	_	_	_
12	from	_	_	IN	_	_	_	_	_
13	an	_	_	DT	_	_	_	_	_
14	entire	_	_	JJ	_	_	_	_	_
15	region	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	it	_	_	PRP	_	_	_	_	_
18	will	_	_	MD	_	_	_	_	_
19	be	_	_	VB	_	_	_	_	_
20	equally	_	_	RB	_	_	_	_	_
21	important	_	_	JJ	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	kill	_	_	VB	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	sexual	_	_	JJ	_	_	_	_	_
26	forms	_	_	NNS	_	_	_	_	_
27	that	_	_	WDT	_	_	_	_	_
28	transmit	_	_	VBP	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	disease	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	"	_	_	``	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	researchers	_	_	NNS	_	_	_	_	_
3	hope	_	_	VBP	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	continue	_	_	VB	_	_	_	_	_
6	research	_	_	NN	_	_	_	_	_
7	toward	_	_	IN	_	_	_	_	_
8	drugs	_	_	NNS	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	prevent	_	_	VB	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	transmission	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	disease	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	science	_	_	NN	_	_	_	_	_
3	was	_	_	VBD	_	_	_	_	_
4	funded	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	groups	_	_	NNS	_	_	_	_	_
7	including	_	_	VBG	_	_	_	_	_
8	UK	_	_	NNP	_	_	_	_	_
9	research	_	_	NN	_	_	_	_	_
10	councils	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	Spanish	_	_	JJ	_	_	_	_	_
14	government	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	U.S.	_	_	NNP	_	_	_	_	_
18	National	_	_	NNP	_	_	_	_	_
19	Institutes	_	_	NNP	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	Health	_	_	NNP	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	European	_	_	NNP	_	_	_	_	_
26	Commission	_	_	NNP	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_

